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The use of iPSCs and tetraploid complementation for human reproductive cloning would raise profound
ethical objections. Professional standards and laws that ban human reproductive cloning by somatic cell
nuclear transfer should be revised to also forbid it by other methods, such as iPSCs via tetraploid comple-
mentation.Induced pluripotent stem cells (iPSCs),
which are genetically matched to a
somatic cell donor, are a powerful re-
search tool that will probably lead to
important discoveries into the mecha-
nisms of disease, stem cell transplanta-
tion, and new methods of evaluating
therapies. Because human iPSCs are
created without destroying embryos,
they avoid many of the moral controver-
sies that surround human embryonic
stem cell (ESC) research.
However, recent publications raise
concerns about the potential use of iPSCs
for human reproductive cloning. Three
research teams have produced mice
that are genetically identical to iPSC lines
by tetraploid complementation (Boland
et al., 2009; Kang et al., 2009; Zhao
et al., 2009), one of several methods of
deriving mice entirely from pluripotent
stem cells (Dechiara et al., 2009; Pouey-
mirou et al., 2007). In tetraploid comple-
mentation, two blastomeres are fused
and cultured to produce a tetraploid
morula or blastocyst. iPSCs are then
combined with this tetraploid embryo,
usually by injection into the blastocyst.
When this entity is transferred and16 Cell Stem Cell 6, January 8, 2010 ª2010 Eimplanted into a uterus, the cells origi-
nating from the tetraploid blastocyst
form the trophoblast and ultimately the
placenta, whereas the developing fetus
is derived from the iPSCs.
These studies provide definitive evi-
dence that at least some iPSCs are
pluripotent. They also raise the possibility
that this technique of tetraploid com-
plementation, or equivalent techniques,
could be used with iPSCs for human
reproductive cloning (Denker, 2009a;
Denker, 2009b). In theory, injecting
human iPSCs into a human tetraploid
blastocyst could create a child who is
a clone of the somatic cell donor and
whose placenta comes from the donor(s)
of the blastomeres.
In this article, we analyze the debates
over human reproductive cloning and
pertinent current legislation and profes-
sional guidelines. Because many current
policies ban only human reproductive
cloning by somatic cell nuclear transfer
(SCNT), we propose policy changes to
also ban other methods, such as iPSCs
via tetraploid complementation, while
not creating barriers to the research use
of iPSCs.lsevier Inc.The Debate over Human
Reproductive Cloning
After the birth of Dolly, the prospect of
using SCNT for human reproductive
cloning generated intense public debate.
Several U.S. and international panels
determined that safety concerns justified
a ban (National Bioethics Advisory
Commission, 1997; National Research
Council and Institute of Medicine, 2002;
The President’s Council on Bioethics,
2002). Animal studies reported birth
defects in offspring, fetal and neonatal
deaths, errors in reprogramming and
imprinting, and medical risks to the preg-
nant animal. Additionally, some people
objected that having a child who has
only one genetic parent and is the genetic
twin of that parent violates cultural norms
regarding reproduction and families and
placed undue expectations on the chil-
dren. Moreover, some critics opposed
nonsexual reproduction, which they
consider violations of divine or natural
law (The President’s Council on Bioethics,
2002). In contrast, others argued that if
human reproductive cloning were shown
to be safe, it should be allowed to respect
the procreative liberty of individuals who
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related children. In their view, nonsafety
arguments against reproductive cloning
were weak and confused (Brock, 2002;
Greely, 2002; Sunstein, 2002).
Currently, safety concerns regarding
iPSCs and tetraploid complementation in
animals justify a prohibition on human
reproductive cloning using this technique.
This ban could be supported now without
resolving the speculative philosophical
issue of whether a ban would be appro-
priate if the technique were safe. We
believe this ban should be in place indefi-
nitely, until there is persuasive evidence of
safety and also societal agreement that
human reproductive cloning is acceptable
as public policy. Two previous U.S.
reports recommended that reproductive
cloning with SCNT be banned for a fixed
period of time, leaving open the possibility
that it might be shown safe and that social
attitudes toward it might change (National
Bioethics Advisory Commission, 1997;
National Research Council and Institute
of Medicine, 2002). However, there are
problems with such a sunset clause. The
choice of a ‘‘sunset’’ date would be arbi-
trary. Furthermore, because the issue is
so sensitive, a policy decision to permit
human reproductive cloning should result
from extensive public and legislative
debate and should not occur simply
because a ban was not renewed. The
recent increased acceptance of human
ESC research illustrates that through
vigorous public debate policy can be
forged on contested issues.The Debate over Research Cloning
Some critics objected to research uses
of SCNT in humans, as well as for
human reproduction. Several distinct
arguments need to be analyzed for their
possible relevance to research uses of
tetraploid complementation with iPSCs.
Such research could help elucidate
early human development, particularly in
the context of specific genetic defects,
the nature of iPSCs, and how they differ
from ESCs.
First, some objected to all human
embryo research and hESC research
because they believe that embryos have
the moral status of persons. Logically,
these critics would support iPSC re-
search, which involves no embryos, but
oppose creation of tetraploid comple-mentation with human iPSCs, which re-
quire blastocysts.
A second objection to SCNT concerned
the intentional production of embryos
expressly for research purposes. A third
objection to SCNT is the risk to women
who would donate oocytes specifically
for research (United Nations General
Assembly, 2005). These objections pose
no barriers to iPSC derivation and re-
search because no embryos or oocytes
are needed. Furthermore, tetraploid com-
plementation with iPSCs for research
purposes does not require fresh oocytes
or embryos created specifically for
research; it might be carried out only
with blastocysts that were created for
reproductive purposes but were no longer
needed for that goal, that would not be
donated to another couple, and that
would otherwise be destroyed.
Fourth, some objected that SCNT in
humans would be a dual-use technology
that could be immediately applied for
ethically inappropriate reproductive pur-
poses. If an SCNT blastocyst could be
produced and developed in the labora-
tory, it could be used either to derive an
SCNT stem cell line or be implanted in
utero for reproductive purposes. Implant-
ing it in utero would not be difficult,
requiring only techniques routinely used
for in vitro fertilization and embryo trans-
fer. Of note, this dual-use objection would
not apply to iPSCs per se. The technical
skills to develop an iPSC stem cell line
would not be sufficient to permit human
reproductive cloning. Additional and diffi-
cult technical skills would be required
for tetraploid complementation, although
current techniques of embryo transfer
could be used for transfer of an iPSC tetra-
ploid blastocyst.
Finally, some raised ‘‘slippery slope’’
objections to research uses of SCNT.
These objections are also relevant to
research uses of tetraploid complementa-
tion with human iPSCs. This technique
might produce a totipotent entity that
could be directly implanted in utero by
standard in vitro fertilization and embryo
transfer procedures. Concerned that a
rogue scientist might attempt to do so,
some people might seek to ban even
research uses of tetraploid complementa-
tion with human iPSCs. To address ‘‘slip-
pery slope’’ concerns, rather than ban-
ning tetraploid complementation with
iPSCs for research purposes, it would beCell Stem Celpreferable to draw a bright line and enact
a strong ban on the undesired activity—
human reproductive cloning.
In summary, many people who oppose
human reproductive cloning with iPSCs
and tetraploid complementation logically
could support using this technique for
research purposes.
Current Laws and Guidelines
on Cloning
Several U.S. and international panels
have recommended a ban on human
reproductive cloning through SCNT (see
Table 1).
Current Laws and Guidelines in the
United States
ThePresident’s Council onBioethics used
the broadest language, rejecting the
production of a new human organism
that is ‘‘genetically virtually identical to
a currently existing or previously existing
human being (The President’s Council on
Bioethics, 2002).’’ The National Bioethics
Advisory Council and National Academy
of Sciences reports explicitly support
SCNT for research purposes, subject to
safeguards and regulation. In contrast,
ten of the seventeen members of the
President’s Council on Bioethics under
President Bush supported a moratorium
on cloning-for-biomedical research with
SCNT.
Currently, 15 states prohibit human
reproductive cloning (Table 1). Although
most laws ban only the use of SCNT,
some are framed in more general terms,
for example to forbid ‘‘replication of
a human being through the production of
a precise genetic copy of nuclear human
DNA’’ or ‘‘replication of a human indi-
vidual.’’ Several states prohibit cloning
for research purposes aswell as for repro-
ductive purposes.
Current International Laws
and Guidelines
International bodies have also opposed
human reproductive cloning (Table 1).
The U.N. has passed a resolution to
prohibit all forms of human cloning ‘‘inas-
much as they are incompatible with
human dignity and the protection of
human life’’ (United Nations General
Assembly, 2005). The Council of Europe
prohibits the creation of a human being
sharing the same nuclear gene set as
another being, living or dead. The Interna-
tional Society for Stem Cell Research
recommends prohibiting gestating orl 6, January 8, 2010 ª2010 Elsevier Inc. 17
Table 1. Summary of Laws and Guidelines Regarding Human Reproductive Cloning
Jurisdiction
Bans
Reproductive
SCNT
Bans the
Creation of
Genetically
Identical Human
Bans
‘‘Replication’’
of an Existing
Human Being
Bans Transfer
of Cloned
Cells In Utero
Bans
‘‘Asexual
Reproduction’’ Comments
U.S. States
Arizona (Arizona State
Legislature, 2005)
O O O Prohibits use
of state monies
Arkansas (Arkansas State
Legislature, 2003)
O O O May also ban SCNT
for research
California (California State
Legislature)
O O O
Connecticut (Connecticut
General Assembly)
O O O O
Indiana (Indiana State Senate) O O O Bans SCNT to create
human embryo
Iowa (Iowa State Legislature) O O Also bans SCNT
for research
Maryland (Maryland State
Senate, 2006)
O O
Massachusetts (Massachusetts
State Senate, 2005)
O O O
Michigan (Michigan State
Legislature, 1999)
O Bans SCNT to create
human embryo
Missouri (Missouri General
Assembly, 2009)
O Prohibits use
of state monies
New Jersey (New Jersey
State Legislature, 2004)
O
North Dakota (North Dakota
State Legislature)
O O
Rhode Island (Rhode Island
State General Assembly)
O O
South Dakota (South Dakota
Legislature, 2004)
Bans attempt to
perform human cloning,
without defining it
Virginia (Virginia General Assembly) O O
Recommendations
National Bioethics Advisory
Commission (National Bioethics
Advisory Commission, 1997)
O Bans attempt to create
a child using SCNT
Institute of Medicine (National
Research Council and Institute
of Medicine, 2002)
O O SCNT expressly
permitted for research
President’s Council on Bioethics
(The President’s Council
on Bioethics, 2002)
O O O Recommends
moratorium on
SCNT for research
International Society for Stem Cell
Research (International Society
for Stem Cell Research, 2006)
O O
American Society for Reproductive
Medicine (ASRM: American Society
for Reproductive Medicine, 2009)
O Bans attempts to clone
International Recommendations and Laws
The Council of Europe
(The Council of Europe, 1998)
O
United Nations Declaration (United
Nations General Assembly, 2005)
Bans all forms of
human cloning,
without defining it
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Table 1. Continued
Jurisdiction
Bans
Reproductive
SCNT
Bans the
Creation of
Genetically
Identical Human
Bans
‘‘Replication’’
of an Existing
Human Being
Bans Transfer
of Cloned
Cells In Utero
Bans
‘‘Asexual
Reproduction’’ Comments
U.S. States
Australia (Australian Government
National Health and Medical
Research Council, 2002)
O O
Canada (House of Commons
of Canada, 2004)
O O Bans creation of an
embryo with diploid
set of chromosomes
from a single human
being
China (Ministry of Health
of China, 2003)
O Bans cloning without
defining the term
France (Parliament
of France, 2003)
Bans cloning without
defining the term
Germany (The Federal Republic
of Germany, 1990)
O O O
Israel (Parliament of Israel, 1999) O O O Time-limited ban
Japan (Japanese Ministry of
Education and Science, 2001)
O O
Singapore (Government
of Singapore, 2005)
O O O
South Korea (Government
of South Korea, 2008)
O O
Sweden (Ministry of health and
Social Affairs of Sweden, 2003)
O O SCNT expressly
permitted for research
United Kingdom (United
Kingdom Office of Public
Sector Information, 2001)
O
References for the policies cited in this table can be found in the Supplemental Information available online. Laws from additional countries can be
found at http://www.hinxtongroup.org/index.html.
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been derived in vitro by nuclear transfer
or nuclear reprogramming into a uterus.
Several countries with major stem cell
research programs also prohibit repro-
ductive cloning (see Table 1). Some coun-
tries, such as China and France prohibit
cloningwithout defining it, whereas others
are far more specific. Japan, for example,
forbids creating an individual with the
same genetic structure as a certain indi-
vidual. The UK and Singapore forbid
transferring in utero an embryo that has
not been created through fertilization.
Recommended Policy Changes
Regarding Human Reproductive
Cloning
Current laws and policies, enacted before
iPSCs were contemplated, have several
shortcomings. For example, some laws
ban only human reproductive cloning bySCNT but not by other methods, such as
iPSC and tetraploid complementation,
injection into eight-cell embryos, parthe-
nogenesis, and embryo splitting. Prohibi-
tions on ‘‘replicating a human being’’ are
flawed. The root meaning of ‘‘replicate’’
is to fold back on itself, and a replica is
an exact or faithful copy of something.
However, there are epigenetic changes
between human iPSCs and donor soma-
tic cells. In addition, some methods of
producing iPSCs may insert genetic
material into the donor cells during the
derivation of the iPSCs, so that the donor
and iPSCs do not have exactly the same
nuclear DNA. It would be preferable to
ban creation of a human being that is
virtually identical genetically to a currently
or previously existing human being.
Even this broader language may not go
far enough. In addition to prohibiting the
creation of a human being through repro-Cell Stem Celductive cloning, it would be reasonable to
ban attempts to do so. Thus we recom-
mend prohibiting the implantation into
a uterus of a totipotent entity that is nearly
identical genetically to a currently existing
or previously existing human being. This
ban should cover transfer into both
human and non-human uteri.
Existing U.S. state laws and guidelines
forbid in vitro culture of human embryos
beyond 14 days of development or after
the appearance of the primitive streak.
These bans prevent research on human
embryos after the individuation and the
development of structural precursors to
the brain (National Bioethics Advisory
Commission, 1999). These prohibitions
should be interpreted to apply to new
techniques whose products have the
organization and structure for normal
human development, such as tetraploid
blastocysts with human iPSCs, injectionl 6, January 8, 2010 ª2010 Elsevier Inc. 19
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and embryo splitting. Such restrictions
should not impede scientifically important
and ethically acceptable research, such
as long-term culture of human embryoid
bodies for deriving differentiated tissues
or cell culture from disaggregated em-
bryos and their clonal derivatives, such
as ESCs. Although such research would
be rejected by those who oppose all
human embryo research, logically it
would be acceptable to those who
support stem cell research with embryos
remaining after a patient has completed
infertility treatment and would otherwise
be destroyed.
Many states and foreign countries do
not ban human reproductive cloning.
Thus, a scientist who wanted to carry
out human reproductive cloning could
do so without legal sanctions in these
jurisdictions. To deter this practice, in
addition to legal prohibitions on human
reproductive cloning, we recommend
that professional societies, including the
American College of Obstetricians and
Gynecologists, the Society for Assisted
Reproductive Technology, the American
Society for Reproductive Medicine, and
the International Society for Stem Cell
Research, should revise their ethical stan-
dards to ban human reproductive cloning
through any technology.
In summary, there continue to be
compelling safety reasons to ban human20 Cell Stem Cell 6, January 8, 2010 ª2010 Ereproductive cloning. Existing laws and
professional guidelines should be care-
fully revised to cover tetraploid comple-
mentation with iPSCs and other tech-
nologies in addition to SCNT, thereby
broadening the ban on attempts at repro-
ductive cloning to existing and future
technologies.
SUPPLEMENTAL INFORMATION
Supplemental Information includes references for
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